Beyond aspirin: how glycoprotein inhibitors ease acute coronary syndromes.
Glycoprotein IIb/IIIa receptor inhibitors can improve vessel patency for patients with myocardial infarction and angina. Patients who receive these drugs can be managed more conservatively, without invasive procedures, and may have less risk of recurrent infarction and death.
MacCallum
E M
EM
Division of Cardiology, Presbyterian Medical Center, University of Pennsylvania Health System, Philadelphia, Pa., USA.
Hanlon
S J
SJ
Byrne
K H
KH
D000208:Acute Disease; D000787:Angina Pectoris / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D013577:Syndrome; D014654:Vascular Patency / Q000187:drug effects
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex